第一单位：
Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.;Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.;The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group.
作者：
Chonlaphat,Sukasem [1]
;
Jirawat,Pratoomwun [2]
;
Patompong,Satapornpong [3]
;
Jettanong,Klaewsongkram [4]
;
Ticha,Rerkpattanapipat [5]
;
Pawinee,Rerknimitr [6]
;
Pattamon,Lertpichitkul [6]
;
Apichaya,Puangpetch [2]
;
Nontaya,Nakkam [7]
;
Parinya,Konyoung [8]
;
Usanee,Khunarkornsiri [8]
;
Wareeporn,Disphanurat [9]
;
Chutika,Srisuttiyakorn [10]
;
Oranuch,Pattanacheewapull [11]
;
Sirimas,Kanjanawart [8]
;
Thachanan,Kongpan [12]
;
Pansu,Chumworathayi [13]
;
Niwat,Saksit [14]
;
Jackrapong,Bruminhent [15]
;
Wichittra,Tassaneeyakul [7]
;
Wasun,Chantratita [16]
;
Munir,Pirmohamed [17]
作者单位：
Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.;Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.;The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group.
[1]
Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.;Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.
[2]
Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.;Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.;Division of General Pharmacy Practice, Department of Pharmaceutical Care, Faculty of Pharmacy, Rangsit University, Pathum Thani, Thailand.
[3]
The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group.;Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, Skin and Allergy Research Unit, Chulalongkorn University, Bangkok, Thailand.;King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
[4]
The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group.;Division of Allergy Immunology and Rheumatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
[5]
The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group.;Division of Dermatology, Department of Medicine, Faculty of Medicine, Skin and Allergy Research Unit, Chulalongkorn University, Bangkok, Thailand.
[6]
Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
[7]
Pharmacy Unit, Udon Thani Hospital, Udon Thani, Thailand.
[8]
The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group.;Division of Dermatology, Department of Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
[9]
The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group.;Division of Dermatology, Department of Medicine, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, Thailand.
[10]
Pharmacy Department, Khon Kaen Hospital, Khon Kaen, Thailand.
[11]
Department of Pathology, Faculty of Medicine, Khon Kaen University, Thailand.
[12]
Pharmacy Unit, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand.
[13]
School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
[14]
Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
[15]
Genomic Medicine Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
[16]
Department of Molecular and Clinical Pharmacology, The Royal Liverpool, Broadgreen University Hospitals NHS Trust, MRC Centre for Drug Safety Science, Liverpool Health Partners, University of Liverpool, Liverpool, UK.
[17]
DOI
10.1002/cpt.1915
PMID
32452529
发布时间
2021-05-25
换一批
